Articles Tagged With:
Loss of Chance Doctrine Claims Can Be Avoided
Loss of chance can be a complicated allegation with the potential for a significant payout. Understanding how such claims arise is the first step in prevention.
Nondisclosure Agreements Should Be Limited in Scope
Malpractice settlement agreements typically include nondisclosure agreements that require plaintiffs to keep the terms confidential, but these clauses can be seen as unfairly keeping the public and other healthcare institutions in the dark about patient safety issues.
Healthcare Organizations Often Paying $1 Million for Cyberattacks
More than a quarter of organizations have suffered a financial loss of at least $1 million from cyberattacks.
Surgeon Who Erred with Liver Suspended in Second State
The surgeon whose license was suspended in Florida for a shocking medical error has had his license suspended in Alabama for that and other incidents.
EDs Are Major Source of Diagnostic Errors
An analysis of closed medical malpractice cases from 2019 to 2023 found that 28% of all diagnostic errors took place in the emergency department, suggesting opportunities for hospitals to focus their efforts in reducing the pernicious problem.
Kickbacks Can Lead to Big Trouble for CEOs, Other Executives
A former Texas hospital chief executive officer has agreed to pay $5.3 million to resolve False Claims Act allegations involving illegal payments to physicians for laboratory referrals in violation of the Anti-Kickback Statute. The case holds lessons for risk managers and their top executives.
Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
This study evaluates the effectiveness of the updated 2021 Paraneoplastic Neurologic Syndromes (PNS)-CARE score in diagnosing PNS, highlighting significant improvements in sensitivity and specificity compared to the 2004 criteria, while also addressing limitations related to study design, diagnostic criteria comparison, and the need for further research in diverse patient populations.
Epilepsy and Cardiovascular Events
This large prospective cohort study found that older adults with a lifetime history of epilepsy were more likely to experience cardiovascular events (CVEs), and that enzyme-inducing antiseizure medications (EIASMs) may account for a significant portion of this risk. The findings suggest a potential causal link between epilepsy treated with EIASMs and CVE, highlighting the need for careful medication selection in epilepsy management.
DOACs Can Safely Be Started Early After Atrial Fibrillation-Associated Stroke
In ischemic stroke associated with atrial fibrillation, early restart of anticoagulation with apixaban one to three days after ischemic stroke, compared to late restart (seven to 14 days), there were no significant differences between the groups in the primary outcome — a composite endpoint including recurrent ischemic stroke, symptomatic intracranial hemorrhage, and systemic embolism.
Neurologic Toxicity with Immune Checkpoint Inhibitors
In a nationwide, multicenter, retrospective study of patients with neurologic immune-related adverse events related to immune checkpoint inhibitors, more than half of patients developed a chronic condition associated with a higher rate of severe neurologic disability and mortality.